Product Recalls in Oregon

Product recalls affecting Oregon — including food, drugs, consumer products, medical devices, and vehicles distributed to Oregon. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,661 recalls have been distributed to Oregon in the last 12 months.

50,914 total recalls
2,661 in last 12 months

Showing 48814900 of 13,369 recalls

DrugDecember 20, 2019· Assurance Infusion

Recalled Item: TESTOSTERONE CYP 200MG/ML OIL INJ in 10 mL vial Assurance Recalled by...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: HYDROMORPHONE 5MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: CLON 750MCG/MORP 30MG/SUF 37.5MCG/ML in 20 mL syringe Assurance Infusion...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2019· Assurance Infusion

Recalled Item: BAC 225MCG/ BUP 4.5MG/ CLON 9MCG/ MORP 3MG/ML ML INJ Recalled by Assurance...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2019· Hikma Pharmaceuticals USA Inc.

Recalled Item: Ketorolac Tromethamine Injection Recalled by Hikma Pharmaceuticals USA Inc....

The Issue: Presence of Particulate Matter: particles identified as polydimethylsiloxane...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2019· Hikma Pharmaceuticals USA Inc.

Recalled Item: Ketorolac Tromethamine Injection Recalled by Hikma Pharmaceuticals USA Inc....

The Issue: Presence of Particulate Matter: particles identified as polydimethylsiloxane...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 16, 2019· Pharmedium Services, LLC

Recalled Item: NORepinephrine Bitartrate 8 mg added to 500 mL 5% Dextrose Recalled by...

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 16, 2019· Pharmedium Services, LLC

Recalled Item: NORepinephrine Bitartrate 4 mg added to 250 mL 5% Dextrose Recalled by...

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 16, 2019· Pharmedium Services, LLC

Recalled Item: NORepinephrine Bitartrate 8 mg added to 250 mL 5% Dextrose Recalled by...

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 16, 2019· Akorn Inc

Recalled Item: Hydrocortisone and Acetic Acid Otic Solution Recalled by Akorn Inc Due to...

The Issue: Subpotent Drug: Low Out of specification (OOS) assay results for the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 13, 2019· The Harvard Drug Group

Recalled Item: Memantine Hydrochloride Extended-release Capsules Recalled by The Harvard...

The Issue: Failed Dissolution Specifications: High out of specification result observed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 13, 2019· Granules India Limited

Recalled Item: RANITIDINE TABLETS Recalled by Granules India Limited Due to CGMP...

The Issue: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 13, 2019· Lupin Pharmaceuticals Inc.

Recalled Item: Bimatoprost Ophthalmic Solution Recalled by Lupin Pharmaceuticals Inc. Due...

The Issue: Failed Impurities/Degradation Specifications: Out-of-specification result...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 11, 2019· Spectrum Laboratory Products

Recalled Item: Estriol [(16a Recalled by Spectrum Laboratory Products Due to Subpotent...

The Issue: Subpotent Drug: Supplier indicated assay results did not meet specifications.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 10, 2019· Lupin Pharmaceuticals Inc.

Recalled Item: Memantine Hydrochloride Extended-release Capsules Recalled by Lupin...

The Issue: Failed Dissolution Specifications: High out of specification result observed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 6, 2019· Lannett Company, Inc.

Recalled Item: Levetiracetam Oral Solution 100mg/mL Recalled by Lannett Company, Inc. Due...

The Issue: Microbial Contamination of Non-sterile Products: Out-of-specification...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 4, 2019· American Health Packaging

Recalled Item: Raloxifene Hydrochloride Tablets Recalled by American Health Packaging Due...

The Issue: Failed Dissolution Specifications: Low out of specification results obtained...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 2, 2019· Jubilant Cadista Pharmaceuticals, Inc.

Recalled Item: Amantadine Hydrochloride Tablets Recalled by Jubilant Cadista...

The Issue: Presence of Foreign Substance: Presence of a foreign object in a single tablet.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 2, 2019· AuroMedics Pharma LLC

Recalled Item: Moxifloxacin Ophthalmic Solution USP Recalled by AuroMedics Pharma LLC Due...

The Issue: Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 27, 2019· Pfizer Inc.

Recalled Item: 25% Dextrose Injection Recalled by Pfizer Inc. Due to Labeling: Incorrect or...

The Issue: Labeling: Incorrect or Missing Lot and/or expiration date.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund